Kamal Adawi

Insider Reports History

Location
Vista, CA
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kamal Adawi:

Company Role Class Num Shares Value Price $ Report Date Ownership
EXAGEN INC. CFO and Corporate Secretary Common Stock 243,749 $465,536 $1.91 04 Mar 2024 Direct
FATE THERAPEUTICS INC Chief Financial Officer Common Stock 100,000 $98,260 $0.9826 15 Jan 2026 Direct
FATE THERAPEUTICS INC Chief Financial Officer Stock Option (Right to Buy) 75,000 15 Jan 2026 Direct

Insider Reports Filed by Kamal Adawi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FATE FATE THERAPEUTICS INC 15 Jan 2026 2 $0 4 Chief Financial Officer 16 Jan 2026, 16:02
FATE FATE THERAPEUTICS INC 20 Oct 2025 2 $0 4 Chief Financial Officer 21 Oct 2025, 16:08
FATE FATE THERAPEUTICS INC 20 Oct 2025 0 $0 3 Chief Financial Officer 21 Oct 2025, 16:07
XGN EXAGEN INC. 04 Mar 2024 2 -$24,407 4 CFO and Corporate Secretary 06 Mar 2024, 16:05
XGN EXAGEN INC. 20 Feb 2024 1 $0 4 CFO and Corporate Secretary 22 Feb 2024, 16:11
XGN EXAGEN INC. 06 Feb 2024 1 -$13,133 4 CFO and Corporate Secretary 08 Feb 2024, 16:05
XGN EXAGEN INC. 02 Mar 2023 1 -$8,432 4 CFO and Corporate Secretary 03 Mar 2023, 15:38
XGN EXAGEN INC. 27 Feb 2023 1 $0 4 CFO and Corporate Secretary 01 Mar 2023, 15:06
XGN EXAGEN INC. 08 Feb 2023 1 -$15,671 4 CFO and Corporate Secretary 10 Feb 2023, 15:05
XGN EXAGEN INC. 01 Mar 2022 1 -$23,076 4 CFO and Corporate Secretary 02 Mar 2022, 15:39
XGN EXAGEN INC. 04 Feb 2022 1 $0 4 CFO and Corporate Secretary 08 Feb 2022, 15:20